StockDuty ← Dashboard Aug 27, 2026 03:43 PM ET
CatalystFDA/Bio

CYTOMX GAINS FAST TRACK STATUS FOR COLORECTAL CANCER ANTIBODY-DRUG CONJUGATE - SEEKINGALPHA

Fast track status accelerates regulatory review for colorectal cancer ADC.

What changed
Why it matters
Fast track status accelerates regulatory review for colorectal cancer ADC.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →